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Background. The aim of this study was to investigate IL-6 and 25-hydroxyvitamin D (25-OH D) associations with muscle size and
muscle function in dialysis patients. Methods. Patients were included in a 16-week control period followed by 16 weeks of high-
intensity resistance training thrice weekly. IL-6 and 25-OHD were analysed after an over-night fast. Muscle fibre size was analysed
in biopsies fromm. vastus lateralis. Muscle power was tested using a Leg Extensor Power Rig. Results. Patients (𝑛 = 36) with IL-6 ≥
6.49 pg/ml (median) were older and had decreased muscle power and a reduced protein intake (𝑃 < 0.05) compared with patients
with IL-6 < 6.49 pg/ml. IL-6 was not associated with muscle fibre size. Vitamin D deficiency (25-OH D < 50 nmol/l) was present
in 51% of the patients and not associated with muscle power. IL-6 remained unchanged during the training period, whilst muscle
power increased by 20–23% (𝑃 < 0.001). Conclusion. Elevated IL-6 values were associated with decreased muscle power but not
with decreased muscle fibre size. Half of the patients were suffering from vitamin D deficiency, which was not associated with
muscle power. IL-6 was unchanged by high-intensity resistance training in dialysis patients in this study.
1. Introduction
Chronic kidney disease (CKD) can arise as the result of
several diseases, among them diabetes. When renal function
is reduced to approximately 10% of the healthy renal capacity
of an individual, dialysis therapy or kidney transplantation
is needed in order to keep the patient alive. The majority
of patients with CKD are treated with haemodialysis thrice
weekly or daily by means of peritoneal dialysis.
Low-grade systemic inflammation with increased levels
of proinflammatory cytokines is common in patients with
CKD [1]. The origin of this low-grade inflammation in
patients with CKD is not clear, but it could be a complica-
tion related to either impaired kidney function or dialysis
treatment per se, or both [2]. The low-grade inflammation
is likely to contribute to the high mortality rate in dialysis
patients via an elevated protein energy waste [3, 4]. Whilst
protein energy waste increases the mortality risk, it may also
affectmusclemass negatively and thereby reduce the patients’
muscle strength. Thus, a direct link between low-grade
inflammation and a decrease in muscle strength impairing
physical performance and reduced ability to perform daily
activities is likely.
In subjects not suffering from CKD, low-grade inflam-
mation is associated with physical inactivity [5]. As physical
inactivity is a common problem in dialysis patients, the
question remains as to whether low-grade inflammation in
these patients can be reduced by physical exercise. Previous
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Table 1: Protocol of 48 exercise sessions covering the 16 weeks of the training.
Exercise Session1–6
Session
7–12
Session
13–24
Session
25–36
Session
37–42
Session
43–48
Leg press (sets ⋅ reps) 4 ⋅ 15 5 ⋅ 15 5 ⋅ 12 5 ⋅ (8–10) 5 ⋅ (6–8) 4 ⋅ (6–8)
Knee extension (sets ⋅ reps) 3 ⋅ 15 3 ⋅ 15 4 ⋅ 12 5 ⋅ (8–10) 5 ⋅ 8 4 ⋅ 8
Knee flexion (sets ⋅ reps) 3 ⋅ 15 3 ⋅ 15 4 ⋅ 12 4 ⋅ 10 4 ⋅ 8 4 ⋅ 8
Reps: repetitions.
studies have not shown any effect of exercise training on low-
grade inflammation in dialysis patients, but the results may
be affected by the training modalities and programs used.
In parallel with low-grade inflammation, vitamin D
deficiency determined as low values of 25-hydroxyvitamin
D (25-OH D) is common in patients with CKD [6–8]. The
vitamin D deficiency in patients with CKD arises from a
diminished exposure to sunlight and through malnutrition.
Vitamin D deficiency has serious implications in terms of
reduced muscle function [9] and an increased mortality risk
in dialysis patients [6]. Furthermore, it is likely that an impact
of vitaminD deficiency onmuscle functionmay be present in
CKD patients even before dialysis therapy is needed [10].The
causality between vitamin D deficiency and reduced muscle
size is not clear, but vitamin D deficiency may impair protein
synthesis leading to muscle waste [11].
Thus, low-grade inflammation and vitamin D deficiency
may have a negative impact on muscle mass and muscle
function in dialysis patients. The aim of this study was to
investigate the effect of resistance training on the proinflam-
matory factor IL-6 as well as the impact of 25-OH D on
muscle size in dialysis patients.
2. Material and Methods
The data from the present study were obtained as part of
a recent study of effects of resistance training in dialysis
patients [12]. The patients were recruited from three dialysis
centres in the Capital Region, Demark, to a control period of
16 weeks without any intervention followed by an interven-
tion period of 16 weeks with resistance training. The study
was performed with three cohorts over three periods of time.
To be included, the participants had to be above 18 years
of age and undergoing haemodialysis or peritoneal dialysis
for more than three months. Exclusion criteria were insulin
treatment, severe diabetic retinopathy, leg amputation, severe
peripheral polyneuropathy, dementia, and an inability to
speak Danish. The capacity of the study program allowed all
included patients to participate.
Comorbidity level was assessed using the Index of Coex-
istent Disease [13]. Food intake was assessed using amodified
7-day version of the Inter99 food frequency questionnaire
[14] and energy intake was determined with the aid of Master
Diætist Data software (Anova A/S, Holte, Denmark).
The tests were conducted with the same relation to the
dialysis schedule at the three tests. Informed consent was
obtained from all patients and the local ethical committee
approved the protocol (H-D-2008-124). The study was reg-
istered on controlled-trials.com no. ISRCTN72099857.
2.1. Training Program. The training consisted of supervised
progressive high-intensity resistance training three times a
week for 16 weeks [12]. The training began with 5 minutes
of warm-up followed by up to 5 sets of dynamic leg press,
dynamic leg extension, and dynamic leg curl, respectively.
The rest period between each set was 60–90 seconds (the
time between repetitions was not regulated). During the
intervention period the load was increased and the number
of repetitions decreased correspondingly from 15 repetitions
in the beginning of the intervention period to 6 repetitions
in the final period (see Table 1). Every set was performed
to exhaustion. The progression during the training period
was adjusted according to changes in 1 repetition maximum
(RM).The 1RM was tested six times in the exercise machines
used in the training program (Technogym, Rotterdam, The
Netherlands) prior to the subperiods presented in Table 1
(first test day 1, week 1). After 5 minutes of warm-up, the
participants completed a full concentric knee extension from
a 90-degree flexionwhile sitting in an upraised position to
test knee extension 1RM. In the 1RM test, the first attempt
was conducted close to an estimated maximum strength and
the following attempts were conducted with an increased
resistance of 2.5 to 10 kg. The muscle strength test was
conducted with a maximum of 6 attempts and the highest
value was accepted as the result. Rest period between each
attempt was 60 seconds. Every participant conducted the
test with the same machine position at “pretraining” and
at “posttraining” test. The load in the leg press exercise
was also determined using the previously described testing
protocol. In the leg press test the participants completed a
full concentric knee extension from 90-degree flexion in the
knee and hip joints. The knee extension and the leg press
tests were conducted on the same days in the presented order.
The training intensity was calculated using the relations 6RM
∼90% of 1RM; 8RM∼86% of 1RM; 10RM∼82% of 1RM; 12RM
∼77% of 1RM; and 15RM ∼71% of 1RM. Three patients did
not feel comfortable during the high loaded 1RM tests, which
were replaced by 6RM tests used in the intensity progression.
The 1RM tests were conducted on training days before the
exercises. The intensity progression during the 16 weeks of
training was in addition to the 1RM tests based on increased
muscle strength observed between the 1RM tests during the
intervention period.Thus, as the patients were able to exceed
the estimated number of repetitions according to the training
protocol, the load was elevated immediately. In the leg curl
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exercise, the intensity was not based on 1RM tests but on the
number of repetitions performed to exhaustion during the
training program.
Whilst the predefined number of repetitions during every
training session was completed in the first two to three sets,
the number of repetitions usually declined in the following
sets as exhaustion was achieved earlier.
2.2. Muscle Power and Physical Function. Leg extensor power
was measured using the Nottingham Leg Extensor Power
Rig. The patients sat in an upright position with their
arms folded across their chest and with their active leg
towards the push-pedal in front of the seat, which made
the direction of movement almost horizontal. The subject
was instructed to push the pedal as hard and as fast as
possible. The measurement was repeated at least five times
and until no further improvement could be recorded on two
consecutive occasions. The data were recorded, computed,
and expressed in watts (W) using the Leg Rig software
package (PC214E; University of Nottingham,Medical Faculty
Workshops, Queen’s Medical Centre, Nottingham, UK).
Physical function was measured using the Chair Stand
Test from the Senior Fitness Test [15]. The test required the
patients to rise to a full standing position and return to a
seated position as frequently as possible within a 30-second
time frame whilst maintaining their arms folded across their
chest at all times.
2.3. Muscle Fibre Analyses. Muscle biopsies were obtained
from the midregion ofm. vastus lateralis on nonhaemodialy-
sis days through a five-millimetre incision using a Bergstro¨m
biopsy needle. Serial sections (10 𝜇m) of the muscle biopsy
sampleswere cut andmyofibrillarATPase histochemistrywas
performed at pH 9.40 after preincubation at pH values 4.37,
4.60, and 10.30 [16]. Computer image analysis was performed
using an image analysis system. Fibres were subsequently
classified as type 1, type 2A, and type 2X [17]. Fibre type sizes
were only performed on the two major fibre types (1 and 2).
Only truly horizontally cut fibres were analyzed.
2.4. Blood Tests. Interleukin-6, 1,25-dihydroxyvitamin D
(1,25-OH
2
D), and 25-OHDwere analysed from blood taken
after an overnight fast and a minimum of 18 hours after the
last training session.
Plasma IL-6 was analysed using an ECLIA kit (Roche
Diagnostics GmbH, Germany). According to the manufac-
turer, the limit of detection for this kit was 1.5 pg/mL, and
the kit has been found to show no cross-reaction with such
substances as IL-1𝛼, IL-1𝛽, IL-2, IL-3, IL-4, IL-8, IFN-𝛾, and
TNF-𝛼. The analyses were performed at the Department of
Clinical Biochemistry, AarhusUniversityHospital, Denmark.
Serum 25-OH D was analysed using an immunological
method that measures both vitamin D 3 and D 2 [18].
Analyses were performed at the Department of Clinical
Biochemistry, Aarhus University Hospital, Denmark. The
lower limit of detection for this analysis was 10 nmol/L. D
vitamin status was categorized as being either normal (25-
OH D ≥ 50 nmol/L) or deficient (25-OH D < 50 nmol/L)
according to the KDIGO guidelines of 2012 [19]. Albumin,
haemoglobin, C-reactive protein (CRP), and bicarbonate
tests were collected from the patients’ clinical practice and
were analysed in the laboratories of the hospitals comprising
those servicing the Capital Region.
2.5. Statistical Analyses. Data distributions were tested using
a Shapiro-Wilk Test. In analyses of variables with nonnor-
mal data distributions nonparametric statistics were used.
Binary correlations were tested using the Spearman Test. The
Wilcoxon Signed Ranks Test or paired Student’s t-test was
used to test for differences between the baseline test and
pretraining and between pre- and posttraining and also to
compare the differences during the control period with any
difference during the training period. The Mann-Whitney
Test or unpaired Student’s 𝑡-test was used to compare groups
of patients. Age adjustments were performed using linear
and logistic regression, and entered analyses and variables
were log-transformed if the residuals were not normally
distributed. Data are presented as the mean ± standard error
of the mean (SEM), count, or percentages. All tests were two-
tailed at a significance level of 𝑃 ≤ 0.05.
3. Results
Thirty-six patients were included and 23 patients completed
the intervention. Six patients dropped out during the control
period and three patients dropped out during the training
period due to problems not related to training. Four patients
completed the intervention but were not retested due to
illness, change of dialysis modality, or problems arising
during blood sampling. Two patients were not included in
the IL-6 measurements and one patient was not included
in the 25-OH D measurements owing to insufficient plasma
collection.
Clinical characteristics are presented in Table 2. There
was no gender difference for IL-6 (females 8.0 ± 2.5 versus
males 9.0 ± 1.4 pg/mL, 𝑃 = 0.290). Interleukin-6 was
positively correlated with age (𝑟 = 0.458, 𝑃 = 0.006) and
CRP (𝑟 = 0.693, 𝑃 = 0.001). At baseline, 51% of the patients
were vitamin D deficient. There was no gender difference for
25-OH D (female 62.0 ± 10.1 versus male 59.1 ± 7.6 nmol/L,
𝑃 = 0.987).
Clinical data in patients with reduced or elevated IL-6 val-
ues (split on themedian 6.49 pg/mL) are presented in Table 3.
Patients with elevated IL-6 values (≥6.49 pg/mL) were sig-
nificantly older, ingested fewer grams of protein⋅day−1⋅kilo−1
body weight, and had impaired muscle power compared to
those with reduced IL-6 values. When muscle power was
age and gender adjusted, low muscle power in the left leg
remained associated with elevated IL-6 values (𝑃 = 0.042),
whereas impaired muscle power in the right leg tended to be
associated with elevated IL-6 values (𝑃 = 0.082).
Mean IL-6 remained stable throughout the control and
training period (Table 5). When the patients were split on the
IL-6 median prior to training (7.4 pg/mL), reduced baseline
IL-6 values (4.8 ± 0.5 pg/mL) and elevated baseline IL-6
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Table 2: Baseline characteristics of the participants.
Parameter Initial cohort 𝑛 = 36
Age (years) 54 ± 2
Gender (f/m) 15/21
Duration of chronic dialysis (years) 5.4 ± 0.9
Dialysis modality (HD/PD) 30/6
Body mass index (kg/m2) 25.0 ± 0.9
Albumin (g/L) 41.2 ± 0.6
Haemoglobin (mmol/L) 7.4 ± 0.2
C-reactive protein (mg/L) 7.2 ± 1.2
Bicarbonate (mmol/L) 25.7 ± 0.6
Comorbidities (score 0–3) 2.3 ± 0.1
Primary renal disease
T2DM 1
Hypertension 4
Polycystic 8
Glomerulonephritis 14
Nephrosclerosis 2
Other/unknown 6
Interleukin-6 (pg/mL) 8.6 ± 1.3
1,25-OH2 D (pmol/L) 31.4 ± 1.8
25-OH D (nmol/L) 60.3 ± 6.0
Normal vitamin D, 25-OH D ≥ 50 nmol/L 49% (𝑛 = 17)
Mild vitamin D deficiency, 25-OH D
25–50 nmol/L 34% (𝑛 = 12)
Moderate vitamin D deficiency, 25-OH D
12.5–25 nmol/L 14% (𝑛 = 5)
Severe vitamin D deficiency, 25-OH D
< 12.5 nmol/L 3% (𝑛 = 1)
F: female; M: male; HD: haemodialysis; PD: peritoneal dialysis. Data are
presented as the mean ± SEM, count, or as a percentage.
values (21.9 ± 4.8 pg/mL) were unchanged after the training
period (data not shown).
The IL-6 values tested prior to and during the training
period did not correlate with changes in muscle power or
muscle morphology during the training period (data not
shown).
Plasma albumin was elevated in patients with normal 25-
OHDcompared to thosewith vitaminDdeficiency (Table 4).
Patients with normal 25-OH D had a reduced percentage of
type 2X muscle fibres and an increased type 1 muscle fibre
size. When 25-OH D was age and season adjusted, normal
25-OH D correlated with the reduced percentage of type 2X
muscle fibres (𝑃 = 0.012) and a reduction in type 1 muscle
fibre size (𝑃 = 0.013).
25-OH D was decreased after the training period
(Table 5). In Figure 1, 25-OH D changes in the control and
training period were stratified according to summer (April to
September) and winter (October to March) periods. During
the control and training periods, 25-OHDchanged according
to the season: during the summer, 25-OH D increased, and
during the winter, the 25-OH D values decreased.
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Figure 1: Changes in 25-OH D during the control period and the
training period.
The 25-OHD status before and during the training period
was not associated with changes in muscle power or muscle
morphology during the training period (data not shown).
However, decreased 25-OHD during the training period was
correlated with an increase in the size of type 2 muscle fibres
(𝑟 = −0.582, 𝑃 = 0.009).
As previously shown,muscle power remained unchanged
during the control period and increased during the training
period (left leg from 2.01 ± 0.21 to 2.48 ± 0.20W/kg, 𝑃 <
0.001, and right leg from 2.11 ± 0.20 to 2.64 ± 0.19W/kg, 𝑃 <
0.001) [12]. Physical function determined by the Chair Stand
Test remained also unchanged during the control period
(from 15.2 ± 1.0 to 15.4 ± 1.3 repetitions, 𝑃 = 0.164) and
increased during the training period (to 18.7 ± 1.7 repetitions,
𝑃 < 0.001) [12]. Muscle power changes during the training
period were not correlated with IL-6 or 25-OH D (data not
shown). As shown previously [20], mean muscle fibre size
was not changed significantly between the pretraining and the
posttraining tests (type 1: 4216 ± 311 versus 4427 ± 392 𝜇m2
and type 2: 3185 ± 233 𝜇m2 versus 3606 ± 275𝜇m2, resp.).
Body weight increased during the training period from 72.8
± 3.7 to 73.9 ± 3.8 kg, 𝑃 = 0.05.
4. Discussion
The main finding in this study was that 16 weeks of resis-
tance training did not affect the level of the circulating
proinflammatory cytokine IL-6 in a well-nourished sample
of dialysis patients with relatively high values of plasma
albumin. In cross-sectional analyses an elevated level of IL-
6 was associated with impaired muscle power and a reduced
protein intake. In addition, half of the patients were found to
be suffering from vitamin D deficiency.
The IL-6 mean value was comparable with values
reported in other studies focusing on skeletal muscle and
exercise training in dialysis patients [21, 22]. In this study,
patients with the most pronounced elevation of IL-6 had
reduced muscle power, whereas no difference was found
in muscle fibre size in-between patients with elevated or
reduced IL-6 levels. Furthermore, an elevated IL-6 level
was not found to affect the lack of muscle hypertrophy
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Table 3: Baseline: interleukin-6 split on the median alongside the age, nutritional status, muscle function, and muscle morphology of the
participants.
Variable IL-6 < 6.49 (pg/mL) (𝑛 = 17) IL-6 ≥ 6.49 (pg/mL) (𝑛 = 17) 𝑃
𝑁 17 17
Age (years) 49.0 ± 3.4 61.2 ± 2.8 0.024
Gender, male (%) 52.9 64.7 0.486
Albumin (g/L) 42.2 ± 0.9 40.1 ± 0.7 0.068
Energy intake (kcal/kg/day) 2345 ± 132 2220 ± 150 0.710
Protein intake (g/kg/day) 1.49 ± 0.09 1.15 ± 0.11 0.019
Muscle power
Leg extension, left (W/kg) 2.37 ± 0.20 1.42 ± 0.11 <0.001
Leg extension, right (W/kg) 2.43 ± 0.21 1.59 ± 0.11 0.002
Muscle fibre type
Type 1 (%) 48.4 ± 3.3 46.5 ± 4.9 0.747
Type 2A (%) 36.3 ± 2.9 37.2 ± 3.1 0.826
Type 2X (%) 15.3 ± 3.5 16.3 ± 3.7 0.935
Muscle fibre size
Type 1 (𝜇m2) 4406 ± 348 4610 ± 320 0.567
Type 2 (𝜇m2) 3526 ± 277 3270 ± 257 0.504
Data are presented as the mean ± SEM or as a percentage.
Table 4: Baseline: 25-OH D status and age, gender, nutritional status, glucose tolerance, muscle power, and muscle morphology for the
participants.
Variable Normal 25-OH D (≥50 nmol/L) 25-OH D deficiency (<50 nmol/L) 𝑃
𝑁 17 18
Age (years) 51 ± 4 55 ± 4 0.525
Gender, male (%) 52 61 0.684
Tested during a summer period (%) 55.6 75.0 0.236
Albumin (g/L) 42.8 ± 0.7 40.1 ± 0.8 0.008
Energy intake (kcal/kg/day) 32.1 ± 2.8 29.9 ± 1.9 0.750
Protein intake (gr/kg/day) 1.39 ± 0.14 1.35 ± 0.10 0.512
Muscle power
Leg extension, left (W/kg) 2.0 ± 0.3 2.0 ± 0.2 0.216
Leg extension, right (W/kg) 2.0 ± 0.3 2.2 ± 0.2 0.379
Muscle fibre type
Type 1 (%) 46 ± 4 45 ± 5 0.491
Type 2A (%) 45 ± 3 33 ± 3 0.053
Type 2X (%) 9 ± 2 22 ± 4 0.022
Muscle fibre size
Type 1 (𝜇m2) 4071 ± 256 5000 ± 366 0.048
Type 2 (𝜇m2) 3783 ± 276 3397 ± 266 0.950
Data are presented as correlation coefficients, the mean ± SEM, or a percentage.
Table 5: Interleukin-6 and 25-hydroxyvitamin D (25-OH D) levels for patients during the study.
Variables Baseline Pretraining Posttraining 𝑃 control period 𝑃 training period 𝑃 in-between periods
IL-6 (pg/mL) 8.8 ± 1.9 14.5 ± 3.3 13.0 ± 3.6 0.063 0.394 0.289
25-OH D (nmol/L) 62.5 ± 8.4 69.1 ± 7.4 59.2 ± 7.5 0.145 0.038 0.167
Data are presented as the mean ± SEM (𝑛 = 23). The control period was between baseline and pretraining; training period was between pre- and posttraining.
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after training in this study. However, a previous study has
suggested that low-grade inflammation disturbs the balance
between protein breakdown and synthesis and is thereby
associated with muscle size in dialysis patients [21]. The
lack of muscle hypertrophy after the present resistance-
training program may be the result of several disturbing
conditions including low-grade inflammation. Uraemia [23],
dialysis per se [24], insulin resistance [25], anabolic hormone
deficiency [26], and acidosis [27] are factors that contribute to
a negative protein balance making the catabolic mechanism
multifactorial. Thus, even though an elevated IL-6 level was
not found to be a limiting factor in this study, it may still play
a role in combination with other factors in the catabolism of
muscle in dialysis patients.
The literature reports that exercise training may decrease
elevated levels of circulating IL-6 in subjects without CKD [5,
28, 29] and in patients with CKD prior to dialysis [30]. Thus,
we hypothesized that resistance training would decrease
elevated IL-6 in dialysis patients. Whilst the mean value of
IL-6 in all patients remained unchanged after training, this
was also true for the subgroup of patients with the highest
IL-6 levels. The fact that IL-6 levels were unchanged after
the resistance training in our patients is supported by two
other trials on dialysis patients [22, 31]. However, a potential
response of exercise training in terms of a decrease in IL-
6 may depend on training modality, dose, and intensity
[28]. Whilst resistance training was used in the present and
the two other previously mentioned studies [22, 31], a pilot
study tested the effect of aerobic exercise on inflammation
in patients treated with dialysis and also found IL-6 to be
unchanged [32]. Based on the present and previous results
[22, 31, 32], we find no reason to believe that exercise training
is effective in combating elevated IL-6 values in dialysis
patients. However, we cannot exclude that a higher dose of
training could be effective and future studies may change the
present conclusions. On the other hand, the lack of effect
of exercise on IL-6 may be explained by the origin of the
low-grade inflammation. As CKD and the dialysis treatment
are important contributors to low-grade inflammation [33],
effects of exercise training on IL-6 may not be possible to
achieve in this patient group due to the nature of the chronic
disease and the indispensable dialysis treatment.
It is well documented that exercise induces acute
increased levels of circulating IL-6, which is stimulated by
contracting muscle [5, 28]. Interleukin-6 therefore not only
is a cytokine but also is recognized as a myokine with an anti-
inflammatory capacity [5]. In the present study it is unknown
as to whether the posttraining levels of IL-6 were affected
by any acute rise after the training sessions. However, as the
lowest IL-6 values also remained unchanged after the training
period, an acute effect of exercise training on IL-6 seems likely
not to have affected the results.
Vitamin D values were in line with data reported in other
studies on dialysis patients [6, 7, 9, 34]. Half of the patients
were suffering from vitamin D deficiency. The 25-OH D
values changed according to the season and may likely be the
result of an increase in exposure to sunlight. The seasonal
changes of 25-OH D were anticipated based on a previous
finding [34].
Vitamin D deficiency in CKD patients is treated to
prevent secondary hyperparathyroidism and osteomalacia.
In addition, treatment with 1,25-dihydroxyvitamin D has in
a retrospective cross-sectional study been suggested to be
associated with greater muscle size and muscle strength in
dialysis patients [10]. However, as the authors did not report
any vitamin D data and only presented the patients as being
treated or not with vitamin D, it is unknown if the vitamin
D values were correlated with muscle size and strength. One
such connection was not supported by the results from our
study. Furthermore, it has also been suggested that vitamin
D status in dialysis patients is associated with the level of
physical activity [34]. In this study 25-OHDdecreased during
the resistance training period, which might be explained by a
seasonal impact. However, resistance training did not hinder
the decrease in 25-OH D and we find no reason to suggest
a positive effect of physical activity on vitamin D status in
this patient group. One interesting finding, however, was that
even though 25-OH D decreased during the training period,
the patients were able to increase their muscle power sig-
nificantly. Furthermore, we found an unexpected significant
correlation between a decrease in 25-OH D and an increase
in type 2 muscle fibre size during the training period. Thus, a
decrease in 25-OH D during a resistance training period did
not limit positive changes inmuscle power, physical function,
nor muscle hypertrophy in dialysis patients.
These results are limited, however, by the relatively low
number of patients. In relation to the data for muscle
size, estimations of muscle mass in the lower extremities
determined by scanning methods would have been relevant
in addition to ameasure ofmuscle size at the fibre level. Scan-
ning methods could have provided additional information
of whole leg muscle mass and intramuscular fat content as
relevant outcomes in this study.
In conclusion, in a well-nourished sample of dialysis
patients, elevated serum IL-6 values were not decreased by a
period of resistance training. Half of the patients were found
to be suffering from vitamin D deficiency. The low-grade
inflammation was associated with reduced muscle power but
not with muscle fibre size. Elevated IL-6 values and vitamin
D deficiency did not affect the positive effects of resistance
training on muscle power and physical function.
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